Sanofi Consumer Healthcare India Ltd

Sanofi Consumer Healthcare India Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, with recent indicators signalling a predominantly bearish outlook despite some pockets of bullishness. The stock’s current price stands at ₹4,003.95, reflecting a slight decline of 0.30% on 22 Sep 2026, as it navigates a challenging market environment marked by mixed technical signals and underperformance relative to benchmark indices.

Sanofi Consumer Healthcare India Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 10 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 13 September 2026, providing investors with the latest insights into its performance and outlook.

Sanofi Consumer Healthcare India Ltd is rated Sell by MarketsMOJO. This rating was last updated on 10 August 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 02 September 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market performance.

Sanofi Consumer Healthcare India Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a bearish trend. The company’s recent downgrade from a Hold to a Sell rating reflects deteriorating price action and weakening market sentiment amid broader sector challenges.

Sanofi Consumer Healthcare India Ltd has recently formed a Death Cross, a significant technical indicator where the 50-day moving average (DMA) crosses below the 200-DMA, signalling a potential shift towards a prolonged bearish trend. This development highlights deteriorating momentum and raises concerns about the stock’s near- and long-term outlook amid already challenging market conditions.

Sanofi Consumer Healthcare India Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 10 August 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 22 August 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook.

Sanofi Consumer Healthcare India Ltd has experienced a notable shift in its technical momentum, transitioning from a sideways trend to a mildly bearish stance. This change is underscored by mixed signals from key technical indicators such as MACD, RSI, Bollinger Bands, and moving averages, reflecting a complex outlook for the pharmaceuticals and biotechnology small-cap stock.

Sanofi Consumer Healthcare India Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a sideways trend. Despite a modest day gain of 1.19%, the stock’s technical indicators present a complex picture, reflecting mixed signals across weekly and monthly timeframes. This analysis delves into the recent technical parameter changes, evaluating momentum oscillators, moving averages, and volume trends to provide a comprehensive view of the stock’s near-term outlook.

Sanofi Consumer Healthcare India Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 10 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 11 August 2026, providing investors with the most up-to-date perspective on the company’s performance and outlook.

Sanofi Consumer Healthcare India Ltd has experienced a subtle shift in its technical momentum, moving from a sideways trend to a mildly bearish stance. Recent technical indicators, including MACD, Bollinger Bands, and moving averages, suggest a nuanced outlook for this small-cap pharmaceutical stock as it navigates a challenging market environment.

Sanofi Consumer Healthcare India Ltd has experienced a notable shift in its technical momentum, transitioning from a mildly bullish stance to a sideways trend. This change is underscored by mixed signals from key technical indicators such as MACD, RSI, Bollinger Bands, and moving averages, reflecting a cautious outlook for investors amid recent price fluctuations.

Sanofi Consumer Healthcare India Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 22 June 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 31 July 2026, providing investors with the most up-to-date perspective on the company’s performance and outlook.

Sanofi Consumer Healthcare India Limited posted a net profit of ₹68.80 crores for Q1 FY27 (June 2026), marking a modest sequential increase of 1.47% from ₹67.80 crores in Q4 FY26 and a robust year-on-year surge of 13.35% from ₹60.70 crores in Q1 FY26. The ₹10,931-crore pharmaceuticals company, trading at ₹4,746.25, has delivered mixed signals with revenue growth tempered by margin compression, even as the stock gained 0.65% following the results announcement.

Sanofi Consumer Healthcare India Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 22 June 2026. While the rating was revised on that date, the analysis and financial metrics presented here reflect the stock's current position as of 20 July 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Sanofi Consumer Healthcare India Ltd has experienced a subtle shift in its technical momentum, moving from a sideways trend to a mildly bullish stance. Despite mixed signals from key indicators such as MACD, RSI, and moving averages, the stock’s recent price action and technical parameters suggest cautious optimism for investors navigating the Pharmaceuticals & Biotechnology sector.

Sanofi Consumer Healthcare India Ltd has experienced a notable shift in its technical momentum, transitioning from a mildly bullish stance to a sideways trend. Recent technical indicators including MACD, RSI, Bollinger Bands, and moving averages reveal a complex picture of price action and momentum, signalling caution for investors amid mixed signals in the Pharmaceuticals & Biotechnology sector.

Sanofi Consumer Healthcare India Ltd has experienced a subtle shift in its technical momentum, moving from a sideways trend to a mildly bullish stance. Despite mixed signals from key indicators such as MACD, RSI, and moving averages, the stock’s recent price action and technical parameters suggest cautious optimism for investors navigating the Pharmaceuticals & Biotechnology sector.